Silence Therapeutics (SLN)
(Delayed Data from NSDQ)
$21.60 USD
-0.22 (-1.01%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $21.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/21/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.47 |
Last EPS Surprise | -88.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.38 |
Next Year | -1.36 |
EPS (TTM) | -1.46 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.53M | 16.66M | 31.22M | 48.43M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 6.37M | 16.76M | 35.65M | 110.48M |
Low Estimate | 2.69M | 16.55M | 24.57M | 9.34M |
Year ago Sales | 13.82M | 11.40M | 31.36M | 31.22M |
Year over Year Growth Est. | -67.22% | 46.10% | -0.45% | 55.10% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.17 | -1.38 | -1.36 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.08 | -0.11 | -0.94 | -2.25 |
High Estimate | -0.08 | -0.11 | -0.94 | -0.17 |
Low Estimate | -0.38 | -0.23 | -1.78 | -2.25 |
Year ago EPS | -0.35 | -0.36 | -1.45 | -1.38 |
Year over Year Growth Est. | 34.29% | 52.78% | 4.83% | 1.69% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 2 | 2 |
Up Last 60 Days | 0 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.17 | -1.38 | -1.36 |
7 Days Ago | -0.23 | -0.17 | -1.38 | -1.36 |
30 Days Ago | -0.30 | -0.37 | -1.45 | -1.18 |
60 Days Ago | -0.30 | -0.37 | -1.45 | -1.18 |
90 Days Ago | -0.30 | -0.37 | -1.45 | -1.18 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.17 | -1.38 | -1.36 |
Zacks Consensus Estimate | -0.23 | -0.17 | -1.38 | -1.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.47 | -0.28 | -0.36 | -0.35 | NA |
Estimate | -0.25 | -0.56 | -0.59 | -0.51 | NA |
Difference | -0.22 | 0.28 | 0.23 | 0.16 | 0.11 |
Surprise | -88.00% | 50.00% | 38.98% | 31.37% | 8.09% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more